Article
Urologists who treat Medicare patients face a 1% pay cut under a Centers for Medicare & Medicaid Services final rule with comment period issued Nov. 1.
RETAIN-2 interim data promising for dose-dense MVAC plus nivolumab in MIBC
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
Casdatifan is linked with promising safety, efficacy in clear cell RCC
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
Disitamab vedotin plus toripalimab shows safety, efficacy in MIBC
Latest LITESPARK-003 data highlight antitumor activity of belzutifan plus cabozantinib